Greenyn Biotechnology Co (ROCO:6846) Total Stockholders Equity : NT$745.6 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Total Stockholders Equity?

Greenyn Biotechnology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$745.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Greenyn Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 was NT$27.75. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Greenyn Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.29.

Greenyn Biotechnology Co Total Stockholders Equity Historical Data

The historical data trend for Greenyn Biotechnology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Total Stockholders Equity Chart

Greenyn Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

388.35

518.32

613.77

562.02

796.91

Greenyn Biotechnology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial										497.89	727.45	758.42	796.91	745.59

Greenyn Biotechnology Co (ROCO:6846) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Greenyn Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(745.59	-	0)	/	26.8639
	=	27.75

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Greenyn Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(159.925	+	53.69)	/	745.59
	=	0.29

Greenyn Biotechnology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenyn Biotechnology Co (ROCO:6846) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No 43 Keya Road, Daya District, Taichung, TWN

Website

https://www.greenynbio.com

Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines